Gene-modified, virus-specific T cell therapy shows promise in treating lymphoma, with little toxicity

Your daily selection of the latest science news! According to Medical Xpress Hodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0 In a first-of-its-kind clinical study, … Continue reading Gene-modified, virus-specific T cell therapy shows promise in treating lymphoma, with little toxicity

Advertisements